Form 4: Immunome Director Sells Shares
Insider Transaction (Form 4)
Isaac Barchas, a Director of Immunome Inc., sold 83,464 shares of common stock on August 10, 2026.
Summary
- Open-market sale: disposed of 10,125 Common Stock at $26.07 ($263,959) on August 10, 2026; holds 62,291 after (Indirect).
- Open-market sale: disposed of 62,291 Common Stock at $26.23 ($1,633,893) on August 11, 2026 (Indirect).
- Open-market sale: disposed of 11,048 Common Stock at $27.25 ($301,058) on August 12, 2026; holds 92,211 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,198,910 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Isaac Barchas — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | Common Stock | 10,125 | $26 | $264.0K | 62,291 |
| 2026-08-11 | Open-market sale | Common Stock | 62,291 | $26 | $1.6M | 0 |
| 2026-08-12 | Open-market sale | Common Stock | 11,048 | $27 | $301.1K | 92,211 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (10,125 shares) |
| 2026-08-11 | Open-market sale (62,291 shares) |
| 2026-08-12 | Open-market sale (11,048 shares) |
Keywords
insider transaction, Form 4, IMNM, Immunome Inc., bearish, Isaac Barchas
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.